Clinical Trials
2
Active:0
Completed:0
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Recovery From Acute Immune Failure in Septic Shock by Immune Cell Extracorporeal Therapy - Observational Long-term Outcome Follow up
Recruiting
- Conditions
- Severe Sepsis
- First Posted Date
- 2023-11-22
- Last Posted Date
- 2024-08-02
- Lead Sponsor
- Artcline GmbH
- Target Recruit Count
- 142
- Registration Number
- NCT06143137
- Locations
- 🇩🇪
Klinikum Magdeburg, Klinik für Intensiv- und Rettungsmedizin, Magdeburg, Germany
🇩🇪Universitätsmedizin Rostock, Abteilung KAI, Rostock, Germany
Recovery From Acute Immune Failure in Septic Shock by Immune Cell Extracorporeal Therapy
- First Posted Date
- 2022-07-05
- Last Posted Date
- 2025-05-25
- Lead Sponsor
- Artcline GmbH
- Target Recruit Count
- 142
- Registration Number
- NCT05442710
- Locations
- 🇩🇪
Universitätsklinikum Regensburg, Klinik für Anästhesiologie, Regensburg, Bayern, Germany
🇩🇪Universitätsklinikum Bonn, Klinik und Poliklinik für Anästhesiologie und Operative Intensivmedizin, Bonn, Nordrhein-Westfalen, Germany
🇩🇪Helios Klinikum Aue, Aue, Sachsen, Germany
News
No news found